SCHEMBL5774739

SCHEMBL5774739

CCOC(=O)c1cnoc1-c1cc(Cl)c(Cl)s1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
BAZ2B Q9UIF8 1/20 0.41
BAZ2A Q9UIF9 1/20 0.41
ALDH1A1 P00352 8/20 0.40
HPGD P15428 4/20 0.40
KDM4E B2RXH2 4/20 0.40
HSD17B10 Q99714 3/20 0.40
GAA P10253 4/20 0.40
MAPK1 P28482 1/20 0.40
CYP4F2 P78329 1/20 0.39
CYP4A11 Q02928 1/20 0.39
SMN1; SMN2 Q16637 4/20 0.38
CASP1 P29466 2/20 0.38
RAB9A P51151 3/20 0.37
NPC1 O15118 2/20 0.37
MAPT P10636 4/20 0.36
KMT2A Q03164 4/20 0.36
MEN1 O00255 3/20 0.36
ALOX15 P16050 2/20 0.36
LMNA P02545 1/20 0.36
L3MBTL1 Q9Y468 2/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5774794 0.82 NPSR1 (0.51) ALDH1A1HPGDKDM4EHSD17B10GAA
SCHEMBL5774581 0.77 ALDH1A1 (0.40) ALDH1A1HPGDKDM4EHSD17B10GAA
SCHEMBL5770551 0.76 SMN1; SMN2 (0.44) BAZ2BBAZ2AALDH1A1HPGDKDM4E
SCHEMBL5775425 0.76 CYP4F2 (0.45) BAZ2BBAZ2AALDH1A1HPGDKDM4E
SCHEMBL5772630 0.76 ALOX5 (0.51) BAZ2BBAZ2AALDH1A1HPGDKDM4E
SCHEMBL5773257 0.75 MAPT (0.51) ALDH1A1HPGDKDM4EHSD17B10MAPK1
SCHEMBL5770512 0.75 MAPT (0.45) ALDH1A1HPGDKDM4EHSD17B10MAPK1
SCHEMBL11382394 0.74 ALOX5 (0.49) ALDH1A1HPGDKDM4EHSD17B10MAPK1
SCHEMBL10668171 0.74 SMN1; SMN2 (0.52) ALDH1A1HPGDKDM4EHSD17B10MAPK1
SCHEMBL5775535 0.73 CYP4F2 (0.42) BAZ2BBAZ2AALDH1A1HPGDKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20060084690-A1 Isoxazole derivatives MOMOSE YU 2006-04-20 US disclosed
US-7022725-B2 Isoxazole derivatives TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2006-04-04 US disclosed
US-20040048908-A1 Isoxazole derivatives TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2004-03-11 US disclosed
EP-1340749-A1 ISOXAZOLE DERIVATIVES Takeda Chemical Industries, Ltd. (JP) 2003-09-03 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060084690-A1 Isoxazole derivatives INSR, GPR119, INSRR BAZ2B 1894/4885BAZ2A 2492/4885ALDH1A1 1045/4885
US-20040048908-A1 Isoxazole derivatives GPR119, INSR, IRS1 BAZ2B 2083/4885BAZ2A 2693/4885ALDH1A1 682/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.